HomeCompareALGN vs ENB

ALGN vs ENB: Dividend Comparison 2026

ALGN yields 1.20% · ENB yields 5.04%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ENB wins by $10.6K in total portfolio value· pulled ahead in Year 4
10 years
ALGN
ALGN
● Live price
1.20%
Share price
$166.26
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$130.06
Full ALGN calculator →
ENB
Enbridge Inc.
● Live price
5.04%
Share price
$54.33
Annual div
$2.74
5Y div CAGR
15.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$32.0K
Annual income
$5,010.05
Full ENB calculator →

Portfolio growth — ALGN vs ENB

📍 ENB pulled ahead of the other in Year 4

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodALGNENB
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ALGN + ENB cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ALGN pays
ENB pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ALGN
Annual income on $10K today (after 15% tax)
$102.25/yr
After 10yr DRIP, annual income (after tax)
$110.55/yr
ENB
Annual income on $10K today (after 15% tax)
$428.48/yr
After 10yr DRIP, annual income (after tax)
$4,258.54/yr
At 15% tax rate, ENB beats the other by $4,147.99/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ALGN + ENB for your $10,000?

ALGN: 50%ENB: 50%
100% ENB50/50100% ALGN
Portfolio after 10yr
$26.7K
Annual income
$2,570.06/yr
Blended yield
9.63%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ALGN right now

ALGN
Analyst Ratings
24
Buy
7
Hold
2
Sell
Consensus: Buy
Price Target
$197.30
+18.7% upside vs current
Range: $140.00 — $220.00
Altman Z
4.9
Piotroski
7/9
ENB
Analyst Ratings
12
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$46.86
-13.7% upside vs current
Range: $42.17 — $63.00
Altman Z
0.8
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ALGN buys
9
ENB buys
10
PoliticianChamberTickerTypeAmountDate
Lisa McClain🏢 House$ALGN▼ Sell$1,001 - $15,0002025-09-11
Lisa McClain🏢 House$ALGN▲ Buy$1,001 - $15,0002025-08-04
Rob Bresnahan🏢 House$ALGN▼ Sell$1,001 - $15,0002025-04-08
Gilbert Cisneros🏢 House$ALGN▼ Sell$1,001 - $15,0002025-02-26
Rob Bresnahan🏢 House$ALGN▲ Buy$1,001 - $15,0002025-02-25
Ritchie Torres🏢 House$ENB▲ Buy$1,001 - $15,0002024-09-26
Ro Khanna🏢 House$ALGN▲ Buy$1,001 - $15,0002024-09-09
Ro Khanna🏢 House$ALGN▲ Buy$1,001 - $15,0002024-09-09
Josh Gottheimer🏢 House$ALGN▼ Sell$1,001 - $15,0002024-05-20
Thomas R. Carper🏛 Senate$ENB▲ Buy$1,001 - $15,0002024-04-11
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricALGNENB
Forward yield1.20%5.04%
Annual dividend / share$2.00$2.74
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.3%
Portfolio after 10y$21.4K$32.0K
Annual income after 10y$130.06$5,010.05
Total dividends collected$1.3K$20.1K
Payment frequencyquarterlyquarterly
SectorStockEnergy
Analyst consensusBuyBuy
Analyst price target$197.30$46.86

Year-by-year: ALGN vs ENB ($10,000, DRIP)

YearALGN PortfolioALGN Income/yrENB PortfolioENB Income/yrGap
1$10,820$120.29$10,701$581.22+$119.00ALGN
2$11,699$121.65$11,538$708.63+$161.00ALGN
3$12,641$122.92$12,547$870.52+$94.00ALGN
4← crossover$13,650$124.13$13,776$1,078.54$126.00ENB
5$14,731$125.27$15,291$1,349.18$560.00ENB
6$15,889$126.34$17,180$1,706.15$1.3KENB
7$17,128$127.36$19,571$2,184.08$2.4KENB
8$18,455$128.31$22,640$2,834.58$4.2KENB
9$19,876$129.21$26,648$3,736.03$6.8KENB
10$21,398$130.06$31,978$5,010.05$10.6KENB

ALGN vs ENB: Complete Analysis 2026

ALGNStock

Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.

Full ALGN Calculator →

ENBEnergy

Enbridge Inc. operates as an energy infrastructure company. The company operates through five segments: Liquids Pipelines, Gas Transmission and Midstream, Gas Distribution and Storage, Renewable Power Generation, and Energy Services. The Liquids Pipelines segment operates pipelines and related terminals to transport various grades of crude oil and other liquid hydrocarbons in Canada and the United States. The Gas Transmission and Midstream segment invests in natural gas pipelines, and gathering and processing facilities in Canada and the United States. The Gas Distribution and Storage segment is involved in natural gas utility operations serving residential, commercial, and industrial customers in Ontario, as well as natural gas distribution and energy transportation activities in Quebec. The Renewable Power Generation segment operates power generating assets, such as wind, solar, geothermal, and waste heat recovery facilities; and transmission assets in North America and Europe. The Energy Services segment provides energy marketing services to refiners, producers, and other customers; and physical commodity marketing and logistical services in Canada and the United States. The company was formerly known as IPL Energy Inc. and changed its name to Enbridge Inc. in October 1998. Enbridge Inc. was founded in 1949 and is headquartered in Calgary, Canada.

Full ENB Calculator →
📬

Get this ALGN vs ENB comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ALGN vs SCHDALGN vs JEPIALGN vs OALGN vs KOALGN vs MAINALGN vs TRPALGN vs OKEALGN vs WMB

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.